Skip To Main Content
Andrew Cave on Muck Rack

Andrew Cave

Verified
Oxford
As seen in: UOL, Forbes, Nature, The Guardian, The Telegraph, Yahoo Finance, Biomed Central (BMC), New Zealand Herald, Thrive Global, City AM and
Journalist, CEO interviewer & award-winning author of 13 books including Secrets of CEOs, The Power of Purpose, Drive to Succeed & Billions to Bust & Beyond.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Andrew

Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

‘No shortage of deals’ as developers await inflation relief

|
By Andrew Cave Verified
| Development Finance Today Verified
By Andrew Cave 6 November 2026 Development finance could surge if costs come under control Getting inflation under control could kickstart a new wave of development finance, giving investors the confidence to buy and encouraging financiers to provide capital. That was the strong theme running through the development finance panel, held at The Finance Professional Show at London Olympia.
Open in Who Shared Issue with article?

Punish the citizens, not cities. Investment in football is about building much more than title-winning teams

|
By Andrew Cave Verified
| LondonlovesBusiness Verified
With the ink hardly dry on the verdict that Manchester City is guilty of 114 rule breaches and disguising secret funding of £831m, plenty of babies are being thrown out alongside bathwater. With appeals pending, the saga may not even have reached half-time but mooted remedies already range from Premier League expulsion and a near-£1bn fine to booting the club into non-league football alongside the likes of Woking and Wealdstone.
Open in Who Shared Issue with article?

Pilot study to validate endothelium collection from pulmonary artery balloon catheter in children

|
By Maxwell Mathias, Charles Sperrazza, Anas Salkini, Andrew Cave Verified, Courtney Griffin, Venkatachalem Sathish, Subhrajit Lahiri
| Nature Verified
Pediatric pulmonary hypertension (PH) has high morbidity and mortality, with an estimated 5-year survival of 75% regardless of underlying cause. Pediatric PH most commonly affects infants born preterm who develop lung disease of prematurity as well as those with congenital heart disease. Current therapies have been adapted from the treatment of adult PH. One barrier to the study of pediatric PH is the lack of live tissue samples or primary cells for research.
Open in Who Shared Issue with article?
See all 261 licensed articles (377 Total)